Tianbao Song

99 Ziyang Road
Wuhan, 430060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

AARS1-Mediated H3K27 Lactylation Rewires Glycolysis to Sustain Aggressive and Recurrent Bladder Cancer.

AARS1-Mediated H3K27 Lactylation Rewires Glycolysis to Sustain Aggressive and Recurrent Bladder Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: February 28, 2026

ADAM12-programmed ECM-CAF remodeling activates PI3K-AKT and enforces an immune-excluded microenvironment to drive bladder cancer progression and therapy resistance.

ADAM12-programmed ECM-CAF remodeling activates PI3K-AKT and enforces an immune-excluded microenvironment to drive bladder cancer progression and therapy resistance.

Journal: Cellular signalling

Published: November 05, 2025

SYMPK interacts with KIF20A and NUMA1 to coordinate spindle organization and safeguard oocyte meiotic maturation.

SYMPK interacts with KIF20A and NUMA1 to coordinate spindle organization and safeguard oocyte meiotic maturation.

Journal: Journal of genetics and genomics = Yi chuan xue bao

Published: October 26, 2025

Tubular-Cell-Derived Extracellular Vesicle miR-491-3p Aggravates Renal Ischemia-Reperfusion Injury by Inhibiting Macrophage SIRT1-Mediated Notch Intracellular Domain Deacetylation-Driven Ubiquitin-Proteasome Degradation.

Tubular-Cell-Derived Extracellular Vesicle miR-491-3p Aggravates Renal Ischemia-Reperfusion Injury by Inhibiting Macrophage SIRT1-Mediated Notch Intracellular Domain Deacetylation-Driven Ubiquitin-Proteasome Degradation.

Journal: Research (Washington, D.C.)

Published: May 12, 2025

FAM111B promotes prostate cancer progression by inhibiting apoptosis via ATF3 suppression and MAPK pathway activation: a novel biomarker and therapeutic target.

FAM111B promotes prostate cancer progression by inhibiting apoptosis via ATF3 suppression and MAPK pathway activation: a novel biomarker and therapeutic target.

Journal: Cancer cell international

Published: January 08, 2025

Lactylation in cancer: Mechanisms in tumour biology and therapeutic potentials.

Lactylation in cancer: Mechanisms in tumour biology and therapeutic potentials.

Journal: Clinical and translational medicine

Published: August 06, 2024

FTH1 overexpression using a dCasRx translation enhancement system protects the kidney from calcium oxalate crystal-induced injury.

FTH1 overexpression using a dCasRx translation enhancement system protects the kidney from calcium oxalate crystal-induced injury.

Journal: Cellular & molecular biology letters

Published: December 27, 2023

EXO1/P53/SREBP1 axis-regulated lipid metabolism promotes prostate cancer progression.

EXO1/P53/SREBP1 axis-regulated lipid metabolism promotes prostate cancer progression.

Journal: Journal of translational medicine

Published: September 27, 2023

BMAL1 inhibits renal fibrosis and renal interstitial inflammation by targeting the ERK1/2/ELK-1/Egr-1 axis.

BMAL1 inhibits renal fibrosis and renal interstitial inflammation by targeting the ERK1/2/ELK-1/Egr-1 axis.

Journal: International immunopharmacology

Published: August 10, 2023

DUSP2 affects bladder cancer prognosis by down-regulating MEK/ERK and P38 MAPK signaling pathways through PTPN7.

DUSP2 affects bladder cancer prognosis by down-regulating MEK/ERK and P38 MAPK signaling pathways through PTPN7.

Journal: Cellular signalling

Published: August 06, 2023

Comprehensive analysis reveals XCL2 as a cancer prognosis and immune infiltration-related biomarker.

Comprehensive analysis reveals XCL2 as a cancer prognosis and immune infiltration-related biomarker.

Journal: Aging

Published: May 15, 2023

Prognostic and immunological roles of IL18RAP in human cancers.

Prognostic and immunological roles of IL18RAP in human cancers.

Journal: Aging

Published: May 06, 2023

Showing 1-12 of 20

Last Updated: 09/26/2026